Skip to content
Screener

Novanta NOVT Total Liabilities & Equity

Total Liabilities & Equity at other companies

Stryker logo
StrykerSYK
$47.93B+3.5%
Coherent logo
CoherentCOHR
$17.29B+19.7%
Intuitive Surgical logo
Intuitive SurgicalISRG
$20.88B+3.5%
Allient Inc. logo
Allient Inc.ALNT
$577.66M-1.6%
Nordson logo
NordsonNDSN
$5.96B-1.6%
Globus Medical logo
Globus MedicalGMED
$5.49B+10.6%

Other financials

Income statement

See full
Revenue$265.8M+10.3%
Gross profit$120.9M+13.3%
Operating income$18.1M+21.1%
Net income$12.5M+179%
EPS (diluted)$0.30+150%

Balance sheet

See full
Cash & equivalents$718.7M+554%
Total debt$285.6M-44.5%
Total equity$1.6B+102%
Total assets$2.1B+41.6%

Cash flow

See full
Operating cash flow$64.9M+331%
CapEx$7.5M+120%
Free cash flow$57.5M+392%

Valuation

See full
Market cap$6.29B+54.6%
Enterprise value$5.86B+30.9%
P/E101.9×+35.5×
P/S6.1×+1.9×

Profitability

See full
Gross margin44.5%-0.2pp
Operating margin9%-2.2pp
Net margin6%-0.4pp
FCF margin11.1%-1.2pp

Returns & leverage

See full
Return on equity5.1%-3.1pp
Debt / equity0.2×-0.5×
Current ratio4.6×+2.0×

Where this comes from

Reported directly by Novanta in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.

The source filing: Novanta’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 5:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-335404
Line itemJuly 3, 2026December 31, 2025
Stockholders’ equity:
Preferred shares, no par value; Authorized shares: 7,000; No shares issued and outstanding
Common shares, no par value; Authorized shares: unlimited; Issued and outstanding: 37,816 and 35,671, respectively423,856423,856
Additional paid-in capital848,434572,057
Retained earnings355,018321,378
Accumulated other comprehensive loss(10,850)(3,004)
Total stockholders' equity1,616,4581,314,287
Total liabilities and stockholders’ equity$2,139,565$1,807,106

Item 1. Financial Statements

FAQ

What is Novanta's total liabilities & equity?
Novanta (NOVT) reported total liabilities & equity of $2.14B in Q2 2026.
How has Novanta's total liabilities & equity changed year-over-year?
Novanta's total liabilities & equity increased by 41.6% year-over-year, from $1.51B to $2.14B.
What is the long-term trend for Novanta's total liabilities & equity?
Over 5 years (2020 to 2025), Novanta's total liabilities & equity has grown at a 15.9% compound annual growth rate (CAGR), from $865.18M to $1.81B.
What does total liabilities & equity mean?
Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.

Ask your AI about Novanta's total liabilities & equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude